Prescription Drugs - Research and Data from KFF

NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care – Chart Pack

May 30, 2002

Poll Finding

New NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care A new survey by NPR, the Kaiser Family Foundation, and Harvard s Kennedy School of Government finds that many Americans have real problems when it comes to accessing and paying for health care, and even if they haven't yet faced a problem, many worry about getting and paying for care in the future. The survey also shows that, while people think helping seniors…

Medicaid Pharmacy Benefits State Fact Sheets

Aug 6, 2020

Interactive

These state fact sheets offer a snapshot of the administration and delivery of Medicaid pharmacy benefits in each state.

Millions of Medicare Beneficiaries Use Prescription Drugs That Could Be Subject to Price Negotiation, But Build Back Better Act Provision Exempts Many Drugs With High Federal Spending

Jan 27, 2022

News Release

Twenty drugs and dozens of insulin products used by 8.5 million Medicare beneficiaries would be subject to government drug price negotiation if the Build Back Better Act (BBBA) were enacted and fully implemented in 2022, according to a new KFF analysis. The 20 drugs include 18 drugs available to beneficiaries covered under Medicare Part D (typically drugs purchased at the pharmacy) and two drugs covered under Medicare Part B (physician-administered drugs). The list includes drugs…

What Could New Anti-Obesity Drugs Mean for Medicare?

May 18, 2023

Policy Watch

In this piece, we discuss Medicare coverage of obesity treatments, the potential cost implications if Medicare covers anti-obesity drugs, and how the Inflation Reduction Act could potentially address these cost concerns.

Web Event: Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs

Event Date: Oct 5, 2016

Event

On Wednesday, October 5, from noon to 1 p.m. ET, the Kaiser Family Foundation will host a web conversation to discuss proposals for controlling prescription drug costs, examine pros and cons of the ideas, and assess the likelihood that the plans will be enacted.

What Are the Current Costs and Outcomes Related to Mental Health and Substance Abuse Disorders?

May 6, 2016

Feature

Mental health and substance use disorders, including addiction to opioids, are the leading cause of disease burden in the United States, and the U.S. has the highest mortality rate for these disorders among similarly wealthy countries. This slideshow explores the prevalence, outcomes, access to care, and costs of mental health disorders and substance abuse in the United States.

Health Care Costs Survey – Summary and Chartpack

Aug 30, 2005

Poll Finding

The summary and chartpack highlight key findings from the joint USA Today/Kaiser/Harvard School of Public Health survey exploring Americans’ views on health care costs. Survey Summary and Chartpack (.pdf)

National Health Spending Explorer

Jan 23, 2026

Interactive

The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, private insurers, and individuals on 15 categories of health services, including hospitals, physician and clinic care, and prescription drugs.

Selected Survey Findings of the Medicare Rx Drug Law – Survey Toplines

Feb 1, 2004

Poll Finding

Seniors are confused about the Medicare prescription drug law. Below are survey toplines of selected findings from the January/February 2004 Kaiser Health Poll Report survey. The findings show that while about two-thirds of seniors report following the debate closely, just 15% say they understand the new prescription drug law very well and seven in 10 don’t know that it passed and was signed into law. Survey Toplines (.pdf)

Prescription Drug Coverage for Medicare Beneficiaries: A Side-by-Side Comparison of S. 1 and H.R. 1 and the Conference Agreement H.R. 1

Nov 1, 2003

Report

This document, prepared by Health Policy Alternatives, Inc., provides a detailed side-by-side comparison of the prescription drug provisions of the Conference Agreement (H.R. 1) passed by the House and Senate in November 2003 and the House (H.R. 1) and Senate (S. 1) Medicare proposals passed in June 2003. Report (.pdf)

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Prescription Drugs

Filter